Complex patterns on HEp-2 indirect immunofluorescence assay in a large sample referred for anti-cell autoantibodies detection.

ANA patterns HEp-2 cells antinuclear antibodies autoantibodies autoimmunity indirect immunofluorescence

Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2023
Historique:
received: 11 07 2023
accepted: 19 12 2023
medline: 30 1 2024
pubmed: 29 1 2024
entrez: 29 1 2024
Statut: epublish

Résumé

The combination of patterns is a frequent and challenging situation in the daily laboratory routine of autoantibodies testing using HEp-2 cells indirect immunofluorescence assay (HEp-2-IFA). Recently, the Brazilian Consensus on Autoantibodies (BCA) named these combinations as complex patterns (CPs) and organized them into 3 subtypes: multiple, mixed, and composite. This study aimed to describe the most frequent combinations of HEp-2-IIF patterns according to this new nomenclature. Routine HEp-2-IFA results reported in January and June 2017 were reviewed using the new BCA classification. Visual pattern recognition was performed by experts on HEp-2-IFA readings, using the International Consensus on Antinuclear Antibodies (ANA) Patterns (ICAP) and BCA recommendations. 54,990 serum samples from different patients were tested for ANA-HEp-2, and 11,478 (20.9%) were positive at a titer ≥ 1/80. Among these positive samples, 1,111 (9.7%) displayed CPs, divided into 95 different combinations. A higher proportion of CPs was observed in the pediatric age group. Multiple, mixed, and composite patterns were present in 85.3, 5.4, and 9.5% of the samples, respectively. In the multiple/mixed pattern group (n=1,005), double, triple, and quadruple combinations (ICAP/BCA codes) were observed in 97.7%, 2.2%, and 0.1%, respectively. The double nuclear pattern was the most prevalent combination observed (67.6%). The most common CPs registered were AC-4 (nuclear fine speckled) + AC-6,7 (nuclear discrete dots) (n=264); AC-2 (nuclear dense fine speckled) + AC-6,7 (n=201); AC-4+AC-8,9,10 (nucleolar) (n=129); and AC-3 (centromere)+AC-4 (n=124). All of these combinations were in the multiple subgroup. Almost 10% of positive results in the HEp-2 procedure displayed CPs. Among the 3 subtypes of CPs proposed, the multiple pattern was the most prevalent, especially in the pediatric population. The AC-4, AC-2, and AC-6,7 were the most prevalent single patterns observed in the combinations described in this study. There was a significant association between age and the prevalence of most combined patterns. The AC-4+AC-6,7 combination was the most prevalent complex pattern detected regardless of the age group. The AC-2+AC-6,7 was more prevalent in younger individuals. The concepts involved in the CPs definition should add value to the reading and interpretation of the HEp-2-IIF assay.

Identifiants

pubmed: 38283335
doi: 10.3389/fimmu.2023.1256526
pmc: PMC10811459
doi:

Substances chimiques

Autoantibodies 0
Antibodies, Antinuclear 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1256526

Informations de copyright

Copyright © 2024 Santos, Cantuária, Félix, Guimarães and de Melo.

Déclaration de conflit d'intérêts

Authors WS, AC, DF and NG were employed by company Sabin Medicina and Health. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Front Med (Lausanne). 2018 Apr 09;5:88
pubmed: 29686987
Adv Rheumatol. 2021 Jun 9;61(1):32
pubmed: 34108043
Clin Pediatr (Phila). 2004 Sep;43(7):637-42
pubmed: 15378151
Ann Rheum Dis. 2019 Jul;78(7):879-889
pubmed: 30862649
Clin Rheumatol. 2019 May;38(5):1293-1299
pubmed: 30617598
J Appl Lab Med. 2022 Jan 5;7(1):322-330
pubmed: 34996073
J Lab Physicians. 2020 Aug;12(2):115-120
pubmed: 32905300
Lupus. 2016 Jul;25(8):797-804
pubmed: 27252255
Clin Chem Lab Med. 2020 Jul 28;58(8):1271-1281
pubmed: 32623848
Clin Chim Acta. 2020 Nov;510:157-159
pubmed: 32645389
J Exp Med. 1991 Jun 1;173(6):1407-19
pubmed: 2033369
J Adolesc Health. 2002 Apr;30(4 Suppl):76-80
pubmed: 11943578
J Rheumatol. 2005 Nov;32(11):2144-9
pubmed: 16265692
Expert Rev Clin Immunol. 2019 Mar;15(3):241-250
pubmed: 30623687
Adv Rheumatol. 2022 Sep 7;62(1):34
pubmed: 36071498
Front Immunol. 2021 Oct 05;12:730102
pubmed: 34675922
Immunol Res. 2021 Dec;69(6):594-608
pubmed: 34625914
Arthritis Rheum. 2012 Jul;64(7):2319-27
pubmed: 22237992
Rheumatol Int. 2022 Feb;42(2):261-271
pubmed: 34755204
Clin Rev Allergy Immunol. 2017 Apr;52(2):202-216
pubmed: 27350273
Arthritis Rheum. 2011 Jan;63(1):191-200
pubmed: 20954189
Hepatol Int. 2012 Dec 05;7(2):775-84
pubmed: 23853697
Auto Immun Highlights. 2016 Dec;7(1):1
pubmed: 26831867
Arthritis Res Ther. 2017 Jun 6;19(1):127
pubmed: 28587625
Auto Immun Highlights. 2016 Dec;7(1):8
pubmed: 27395414
Rev Bras Reumatol. 2014 Jan-Feb;54(1):44-50
pubmed: 24878791
Front Immunol. 2022 Mar 18;13:840960
pubmed: 35371074
J Clin Lab Anal. 2020 Dec;34(12):e23546
pubmed: 33047841
Adv Rheumatol. 2019 Jul 3;59(1):28
pubmed: 31269997
J Clin Med. 2021 Aug 28;10(17):
pubmed: 34501315
Front Immunol. 2022 Jan 19;12:798322
pubmed: 35126363
PLoS One. 2021 Jan 7;16(1):e0244950
pubmed: 33411840
Clin Epidemiol. 2016 Dec 20;9:1-8
pubmed: 28053555
J Autoimmun. 2010 Nov;35(3):276-90
pubmed: 20650611
J Rheumatol. 2014 Jul;41(7):1405-8
pubmed: 24737914
Asian Pac J Allergy Immunol. 2005 Jun-Sep;23(2-3):153-7
pubmed: 16252846
Curr Ther Res Clin Exp. 2014 Nov 26;76:116-9
pubmed: 25473438
Clin Chem Lab Med. 2018 Sep 25;56(10):1783-1788
pubmed: 29813025
Arthritis Rheumatol. 2020 Jun;72(6):1026-1035
pubmed: 32266792
Diagnostics (Basel). 2023 Jan 07;13(2):
pubmed: 36673033
Arthritis Rheum. 2006 Sep;54(9):3051-6
pubmed: 16948135
J Autoimmun. 2006 Feb;26(1):42-51
pubmed: 16246523
J Transl Autoimmun. 2022 Jan 19;5:100145
pubmed: 35128372
Adv Rheumatol. 2022 Aug 15;62(1):32
pubmed: 35971154

Auteurs

Wilton Ferreira S Santos (WFS)

Immunology Division, Sabin Medicina and Health, Brasília, Brazil.

Ana Paula de Castro Cantuária (APC)

Immunology Division, Sabin Medicina and Health, Brasília, Brazil.

Daniele de Castro Félix (DC)

Immunology Division, Sabin Medicina and Health, Brasília, Brazil.

Natália Carvalho Guimarães (NC)

Immunology Division, Sabin Medicina and Health, Brasília, Brazil.

Igor Cabral Santos de Melo (ICS)

Long-term Care Unit, Hospital Geral de Fortaleza, Fortaleza, Ceará, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH